Company intelligence / Profile preview

City Drugs Specialty Pharmacy

New York, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

City Drugs Specialty Pharmacy is a New York-based specialty pharmacy providing high-touch dispensing and support services for complex, rare, and chronic conditions (including hepatitis, oncology, autoimmune, and gastroenterology) and was acquired in 2020 by BioMatrix Specialty Pharmacy to expand its national specialty pharmacy footprint.[1][5][13]

Therapeutic areas: ImmunologyOtherInfectious DiseasesRare DiseasesGastroenterologyOncology
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on City Drugs Specialty Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on City Drugs Specialty Pharmacy.

Explore the full profile